Does greater platelet inhibition explain abciximab's superiority in the TARGET trial? A randomized clinical comparison. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Swierkosz, TA
  • Kapoor, S
  • Tardiff, DC
  • Hirshfeld, JW
  • Klugherz, BD
  • Kolansky, DM
  • Magness, K
  • Valettas, Nicholas
  • Wilensky, RL
  • Herrmann, HC

publication date

  • October 23, 2001